Ausgabe 5/2016
Inhalt (12 Artikel)
Host–virus interactions in hepatitis B and hepatitis C infection
Sachiyo Yoshio, Tatsuya Kanto
Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience
Hitoshi Maruyama, Tadashi Sekimoto, Osamu Yokosuka
Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan
Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras
Yasuo Kawaguchi, Takao Hinoi, Yasufumi Saito, Tomohiro Adachi, Masashi Miguchi, Hiroaki Niitsu, Tatsunari Sasada, Manabu Shimomura, Hiroyuki Egi, Shiro Oka, Shinji Tanaka, Kazuaki Chayama, Kazuhiro Sentani, Naohide Oue, Wataru Yasui, Hideki Ohdan
Esophageal motility after peroral endoscopic myotomy for achalasia
Yue Hu, Meng Li, Bin Lu, Lina Meng, Yihong Fan, Haibiao Bao
Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis
Harunobu Sato, Koutaro Maeda, Kenjiro Kotake, Kenichi Sugihara, Hiroshi Takahashi
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features
Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Takako Watanabe, Satoshi Otani, Miki Taniguchi, Fumio Goto, Hiroko Nagata, Shun Kaneko, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Seishin Azuma, Yasuhiro Itsui, Mina Nakagawa, Minoru Tanabe, Shinichi Takano, Mitsuharu Fukasawa, Minoru Sakamoto, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability
Wai-Kay Seto, Ka-Shing Cheung, Danny Ka-Ho Wong, Fung-Yu Huang, James Fung, Kevin Sze-Hang Liu, Ching-Lung Lai, Man-Fung Yuen
Appropriate use of virtual touch quantification and FibroScan® M and XL probes according to the skin capsular distance
Erina Kumagai, Keiko Korenaga, Masaaki Korenaga, Masatoshi Imamura, Misuzu Ueyama, Yoshihiko Aoki, Masaya Sugiyama, Kazumoto Murata, Naohiko Masaki, Tatsuya Kanto, Masashi Mizokami, Sumio Watanabe
Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?
Takeshi Yamada, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Ichisnosuke Hyodo
Reply to the letter by Takeshi Yamada et al. concerning “Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?”
Jun Zhou, Zhi Peng, Lin Shen
Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
Jun Zhou, Zhi Peng, Yi Liu, Jifang Gong, Xiaotian Zhang, Ming Lu, Jing Gao, Yili Li, Yanyan Li, Lin Shen